Please login to read the full article.
Scrip Regulatory Affairs
Canada consults on use of foreign review reports in evaluation of drugs, devices
28 September 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Canada consults on proposed changes to clinical trials guideline for drugs
- Delay in China's review time for drugs likely to continue; review predictability and transparency improve
- US guidance explains which TV drug ads will be subject to FDA's 45-day pre-review rule
- US FDA issues much-awaited draft guidelines on developing biosimilars
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
